Proposed Data Collection Submitted for Public Comment and Recommendations, 26687-26688 [2018-12373]

Download as PDF Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–18–0969; Docket No. CDC–2018– 0044] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Monitoring Changes in Attitudes and Practices among Family Planning Providers and Clinics. This project seeks to obtain information on changes in attitudes and practices among family planning providers and clinics in the United States related to recommendations from national contraception guidelines. DATES: CDC must receive written comments on or before August 7, 2018. ADDRESSES: You may submit comments, identified by Docket No. CDC–2018– 0044 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton amozie on DSK3GDR082PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 16:53 Jun 07, 2018 Jkt 241001 Road NE, MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project Monitoring Changes in Attitudes and Practices among Family Planning Providers and Clinics (OMB No. 0920– 0969, exp. 5/31/2014)—Reinstatement with Change—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Division of Reproductive Health (DRH) at the Centers for Disease Control and Prevention (CDC) and the HHS Office of Population Affairs (OPA) develop and disseminate guidance to improve the use of contraception and the delivery of quality family planning services. The U.S. Medical Eligibility PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 26687 Criteria for Contraceptive Use (US MEC), the first national guidance on family planning containing evidencebased recommendations for the safe use of contraceptive methods for women and men with specific characteristics and medical conditions, was first published by the CDC in June 2010. The US Selected Practice Recommendations for Contraceptive Use (US SPR), which provides guidance on how to use contraceptive methods safely and effectively once they are deemed to be medically appropriate, was first published by the CDC in June 2013. The US MEC and US SPR were updated after review of the scientific evidence and consultation with national experts in family planning; the revised US MEC and US SPR were published in August 2016. Providing Quality Family Planning Services (QFP), which provides evidence-informed recommendations to improve client care and service delivery infrastructure to support the provision of quality family planning services to women and men of reproductive age in the United States, was published by CDC and OPA in April 2014. The US MEC, US SPR, and QFP have been widely disseminated to health care providers and other constituents via professional organizations, federal program grantees, scientific and programmatic meetings, scientific manuscripts, online resources, and other avenues. To monitor changes in attitudes and practices regarding provision of contraception among family planning providers and clinics, we initiated a multi-phase assessment. In 2009–2010, CDC carried out the first phase of the assessment, collecting information before the release of the US MEC (OMB No. 0920–0008). In 2013–2014, CDC, in collaboration with OPA, carried out the second phase of the assessment, collecting information before the release of the US SPR and QFP (OMB No. 0920– 0969). These information collections provided useful knowledge about attitudes and practices of family planning providers. CDC and OPA used the findings to develop educational materials and opportunities for health care providers. In 2018, in collaboration with OPA, CDC plans to request a reinstatement of OMB No. 0920–0969, ‘Monitoring Changes in Attitudes and Practices among Family Planning Providers and Clinics’ to carry out the third phase of the assessment. As in the previous phases, the information collection will allow CDC and OPA to improve family planning-related practice by: (1) Understanding the current use of contraception guidance in practice, E:\FR\FM\08JNN1.SGM 08JNN1 26688 Federal Register / Vol. 83, No. 111 / Friday, June 8, 2018 / Notices including awareness and use of the US MEC, US SPR and QFP; (2) describing current attitudes and practices among family planning providers and clinics related to recommendations included in the US MEC, US SPR, and QFP and assessing changes from previous data collections; and (3) identifying training needs in use of guidance and family planning service delivery (e.g., provider tools, continuing education modules). As in previous phases of data collection, CDC plans to administer formatting, usability, and data quality. OMB approval is requested for one year. The estimated burden per response for providers is 15 minutes and has not changed since the previous OMB approval. The estimated burden per response for administrators will be reduced from 40 minutes to 35 minutes. The total burden for participants is estimated at 1,916 hours. Participation is voluntary and there are no costs to respondents other than their time. surveys to private and public sector family planning providers and clinic administrators in the United States. The design, methodology, and analytic approach that CDC plans to implement are based on methods previously approved for the 2013–2014 survey, with different instruments being administered to providers and clinic administrators. Minor changes to survey content will be made to eliminate unnecessary questions, add new questions of interest, and improve ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Type of respondents Form name Office-based physicians (private sector). 2018–2019 Survey of Health Care Providers about Family Planning Attitudes and Practices. 2018–2019 Survey of Health Care Providers about Family Planning Attitudes and Practices. 2018–2019 Survey of Health Care Providers about Family Planning Attitudes and Practices. 2018–2019 Survey of Administrators of Health Centers that Provide Family Planning. 2018–2019 Survey of Administrators of Health Centers that Provide Family Planning. 1,000 1 15/60 250 1,000 1 15/60 250 1,000 1 15/60 250 1,000 1 35/60 583 1,000 1 35/60 583 ........................................................... ........................ ........................ ........................ 1,916 Title X clinic providers (public sector) Non-Title X publicly funded clinic providers (public sector). Title X clinic administrators (public sector). Non-Title X publicly funded clinic administrators (public sector). Total ........................................... Jeffrey M. Zirger, Acting Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2018–12373 Filed 6–7–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–18–18ACN; Docket No. CDC–2018– 0042] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. amozie on DSK3GDR082PROD with NOTICES1 AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the SUMMARY: VerDate Sep<11>2014 16:53 Jun 07, 2018 Jkt 241001 general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Undetermined cause of Serratia marcescens infections—Multiple States, 2018. The goal of this investigation is to identify potential risk factors leading to an outbreak of Serratia marcescens infections among U.S. healthcare patients. Data will be used to identify a cause of the infections and prevent additional events from occurring. DATES: CDC must receive written comments on or before August 7, 2018. ADDRESSES: You may submit comments, identified by Docket No. CDC–2018– 0042 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed E:\FR\FM\08JNN1.SGM 08JNN1

Agencies

[Federal Register Volume 83, Number 111 (Friday, June 8, 2018)]
[Notices]
[Pages 26687-26688]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12373]



[[Page 26687]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-0969; Docket No. CDC-2018-0044]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Monitoring Changes in Attitudes 
and Practices among Family Planning Providers and Clinics. This project 
seeks to obtain information on changes in attitudes and practices among 
family planning providers and clinics in the United States related to 
recommendations from national contraception guidelines.

DATES: CDC must receive written comments on or before August 7, 2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0044 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Monitoring Changes in Attitudes and Practices among Family Planning 
Providers and Clinics (OMB No. 0920-0969, exp. 5/31/2014)--
Reinstatement with Change--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    The Division of Reproductive Health (DRH) at the Centers for 
Disease Control and Prevention (CDC) and the HHS Office of Population 
Affairs (OPA) develop and disseminate guidance to improve the use of 
contraception and the delivery of quality family planning services. The 
U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC), the 
first national guidance on family planning containing evidence-based 
recommendations for the safe use of contraceptive methods for women and 
men with specific characteristics and medical conditions, was first 
published by the CDC in June 2010. The US Selected Practice 
Recommendations for Contraceptive Use (US SPR), which provides guidance 
on how to use contraceptive methods safely and effectively once they 
are deemed to be medically appropriate, was first published by the CDC 
in June 2013. The US MEC and US SPR were updated after review of the 
scientific evidence and consultation with national experts in family 
planning; the revised US MEC and US SPR were published in August 2016. 
Providing Quality Family Planning Services (QFP), which provides 
evidence-informed recommendations to improve client care and service 
delivery infrastructure to support the provision of quality family 
planning services to women and men of reproductive age in the United 
States, was published by CDC and OPA in April 2014. The US MEC, US SPR, 
and QFP have been widely disseminated to health care providers and 
other constituents via professional organizations, federal program 
grantees, scientific and programmatic meetings, scientific manuscripts, 
online resources, and other avenues.
    To monitor changes in attitudes and practices regarding provision 
of contraception among family planning providers and clinics, we 
initiated a multi-phase assessment. In 2009-2010, CDC carried out the 
first phase of the assessment, collecting information before the 
release of the US MEC (OMB No. 0920-0008). In 2013-2014, CDC, in 
collaboration with OPA, carried out the second phase of the assessment, 
collecting information before the release of the US SPR and QFP (OMB 
No. 0920-0969). These information collections provided useful knowledge 
about attitudes and practices of family planning providers. CDC and OPA 
used the findings to develop educational materials and opportunities 
for health care providers.
    In 2018, in collaboration with OPA, CDC plans to request a 
reinstatement of OMB No. 0920-0969, `Monitoring Changes in Attitudes 
and Practices among Family Planning Providers and Clinics' to carry out 
the third phase of the assessment. As in the previous phases, the 
information collection will allow CDC and OPA to improve family 
planning-related practice by: (1) Understanding the current use of 
contraception guidance in practice,

[[Page 26688]]

including awareness and use of the US MEC, US SPR and QFP; (2) 
describing current attitudes and practices among family planning 
providers and clinics related to recommendations included in the US 
MEC, US SPR, and QFP and assessing changes from previous data 
collections; and (3) identifying training needs in use of guidance and 
family planning service delivery (e.g., provider tools, continuing 
education modules).
    As in previous phases of data collection, CDC plans to administer 
surveys to private and public sector family planning providers and 
clinic administrators in the United States. The design, methodology, 
and analytic approach that CDC plans to implement are based on methods 
previously approved for the 2013-2014 survey, with different 
instruments being administered to providers and clinic administrators. 
Minor changes to survey content will be made to eliminate unnecessary 
questions, add new questions of interest, and improve formatting, 
usability, and data quality. OMB approval is requested for one year. 
The estimated burden per response for providers is 15 minutes and has 
not changed since the previous OMB approval. The estimated burden per 
response for administrators will be reduced from 40 minutes to 35 
minutes. The total burden for participants is estimated at 1,916 hours. 
Participation is voluntary and there are no costs to respondents other 
than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Office-based physicians         2018-2019 Survey           1,000               1           15/60             250
 (private sector).               of Health Care
                                 Providers about
                                 Family Planning
                                 Attitudes and
                                 Practices.
Title X clinic providers        2018-2019 Survey           1,000               1           15/60             250
 (public sector).                of Health Care
                                 Providers about
                                 Family Planning
                                 Attitudes and
                                 Practices.
Non-Title X publicly funded     2018-2019 Survey           1,000               1           15/60             250
 clinic providers (public        of Health Care
 sector).                        Providers about
                                 Family Planning
                                 Attitudes and
                                 Practices.
Title X clinic administrators   2018-2019 Survey           1,000               1           35/60             583
 (public sector).                of
                                 Administrators
                                 of Health
                                 Centers that
                                 Provide Family
                                 Planning.
Non-Title X publicly funded     2018-2019 Survey           1,000               1           35/60             583
 clinic administrators (public   of
 sector).                        Administrators
                                 of Health
                                 Centers that
                                 Provide Family
                                 Planning.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           1,916
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of 
Scientific Integrity, Office of the Associate Director for Science, 
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-12373 Filed 6-7-18; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.